Clinical trials: Injections, open to volunteers
HIV
Recombinant Human Interleukin-7 (JL18008) for the Treatment of HIV-Infected Immunological Non-Responders
JL18008 Injection is designed to improve the immune response in cART-treated HIV-infected immunological non-responders (HIV INRs).
- Trial name
- NCT07443228
- Testing
- JL18008
- Volunteers
- 52 people
- Sponsor
- Jecho Biopharmaceuticals Co., Ltd.
Solid Tumor
HS-IT101 Injection in the Treatment of Advanced Solid Tumors
Single-arm, open-label,interventional study evaluating adoptive cell therapy (ACT) with autologous tumor-infiltrating lymphocyte (TIL) infusion (HS-IT101) after lymphodepletion preparative with fludarabine and cyclophosphamide…
- Trial name
- NCT06342336
- Testing
- HS-IT101 Injection
- Where
- China
- Volunteers
- 44 people
- Sponsor
- Hangzhou Huasai Biomedicine Co., Ltd.
Relapsed/Refractory Hematological Malignancies
A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies
This study is an open-label, dose-escalation and efficacy-expansion Phase I clinical trial to evaluate the safety, tolerability, PK profile, immunogenicity, and preliminary antitumor activity of QLS2313 as a monotherapy in…
- Trial name
- NCT07294300
- Testing
- QLS2313
- Where
- China
- Volunteers
- 124 people
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
Breast Cancer, Pain Management
Nonpharmacological Management of Pain and Fear During Hormone Injection in Breast Cancer Patients
This randomized controlled study will compare the effects of the ShotBlocker device and the Helfer Skin Tap Technique on pain and fear during intramuscular hormone injections in premenopausal and postmenopausal breast cancer…
- Conditions
- Breast Cancer, Pain Management, Fear, Injection Fear
- Trial name
- NCT07406165
- Testing
- ShotBlocker device, This involves rhythmic, gentle tapping with the fingertips on the skin surrounding the gluteal injection site.
- Where
- Turkey (Türkiye)
- Volunteers
- 99 people
- Sponsor
- Inonu University
Cervical Cancer, Gynecologic Malignancies
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
Recombinant oncolytic adenovirus injection (KD01)is an oncolytic vius product. Its main component is a conditionally replicativerecombinant human type 5 adenovirus, where part of the E3 region has been replaced with the gene…
- Conditions
- Cervical Cancer, Gynecologic Malignancies, Endometrial Cancer
- Trial name
- NCT06552598
- Testing
- KD01(the recombinant oncolytic adenovirus)
- Where
- China
- Volunteers
- 97 people
- Sponsor
- Tongji Hospital
Shoulder Tendinitis
Hyaluronic Acid in Shoulder Tendinopathy
Multicentric, randomised study to compare the effectiveness on activity pain at 3 months of corticosteroid injection associated with hyaluronic acid with corticosteroids injection alone in patients with tendinopathy of the…
- Trial name
- ACCTE (NCT06376981)
- Testing
- Hyaluronic acid injection, Corticosteroid injection
- Where
- 2 sites in France
- Volunteers
- 132 people
- Sponsor
- Centre Hospitalier Departemental Vendee
B Cell Malignancies
Exploratory Study on the Treatment of Relapsed and Refractory B-cell Malignant Tumors With WGb-0301 Injection
Malignant hematological tumors mainly derived from adult B cells are mainly acute lymphoblastic leukemia (ALL) and non Hodgkin lymphoma (NHL).
- Trial name
- NCT07332663
- Testing
- WGb-0301 injection
- Volunteers
- 9 people
- Sponsor
- Sichuan University
Pancreatic Cancer Metastatic to Liver
Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety
1. Evaluation of adebelimab in combination with irinotecan liposomes, oxaliplatin, fluorouracil, efficacy and safety of leucovorin in the first-line treatment of advanced metastatic pancreatic cancer 2.
- Trial name
- NCT06531278
- Testing
- Irinotecan liposome, Adebrelimab, Oxaliplatin
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Jiang Long
NSCLC (Advanced Non-small Cell Lung Cancer), Colorectal Cancer
Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors
This is a prospective, open-label, exploratory clinical study to evaluate the safety and preliminary efficacy of allogeneic natural killer (NK) cell injection combined with standard maintenance therapy in patients with locally…
- Conditions
- NSCLC (Advanced Non-small Cell Lung Cancer), Colorectal Cancer, Advanced Solid Tumors, Advanced Hepatocellular Carcinoma (HCC)
- Trial name
- NCT07551778
- Testing
- NK Cells, NK cells + PD-(L)1 inhibitor + pemetrexed as first-line maintenance therapy, NK cells + cetuximab/bevacizumab + capecitabine as first-line maintenance therapy
- Volunteers
- 42 people
- Sponsor
- BOE Technology Group Co., Ltd.
Diabetic Nephropathy
Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy
Diabetic nephropathy (DN) is one of the most significant microvascular complications of diabetes mellitus. Its incidence can reach 30%-40% after 20 years of diabetes duration, among which 5%-10% of patients will progress to…
- Trial name
- NCT07822152
- Testing
- UC-MSCs
- Where
- China
- Volunteers
- 15 people
- Sponsor
- Tongji Hospital
Acne Scars, Acne Scars - Atrophic
Efficacy of Stromal Vascular Fraction on Acne Scar Correction
This study aims to evaluate the efficacy and safety of intradermal injection of autologous stromal vascular fraction (SVF) in the treatment of atrophic acne scars.
- Trial name
- NCT07094958
- Testing
- stromal vascular fraction (SVF), Normal Saline (NS)
- Volunteers
- 16 people
- Sponsor
- Seoul National University Hospital
Advanced Malignancies
A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies
This is a Phase I, multicenter, open-label, single-arm and first-in-human clinical study of BRY812 for injection. The study objectives are to evaluate the safety, tolerability, pharmacokinetic profile, anti-tumor activity and…
- Trial name
- NCT06038058
- Testing
- BRY812 for injection
- Where
- China
- Volunteers
- 164 people
- Sponsor
- BioRay Pharmaceutical Co., Ltd.
HIV Infections, Contraception
Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV
This study is being done to understand how long-acting injectable cabotegravir (CAB-LA) used for HIV pre-exposure prophylaxis (PrEP) and hormonal contraceptive methods affect each other when used at the same time.
- Conditions
- HIV Infections, Contraception, Drug-drug Interaction, PrEP
- Trial name
- PHARAOH (NCT07516548)
- Testing
- Long-acting injectable cabotegravir (CAB-LA), No PrEP
- Where
- Botswana
- Volunteers
- 105 people, healthy volunteers welcome
- Sponsor
- University of Alabama at Birmingham
Periorbital Hollowing, Skin Aging
Clinical Research on Deep-Plane Rejuran S Injection for Improvement in the Apperance of Periorbital Hollowing Using a Cannula Technique
The goal of this clinical study is to learn whether DOT PN (Rejuran S), a polynucleotide injectable gel, improves periorbital hollowing (a sunken look around the eyes) in adults aged 25 to 65 years when injected into the deep…
- Trial name
- NCT07912814
- Testing
- DOT PN (Rejuran S)
- Where
- 3 sites in Malaysia, Singapore and 1 more
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- PharmaResearch Co.,Ltd
Sepsis-Induced Myocardial Dysfunction
Investigating the Clinical Benefits and Underlying Mechanisms of Danhong Injection in Modulating Mitochondrial Homeostasis Against Sepsis-Associated Myocardial Dysfunction
This study aims to evaluate the clinical efficacy of Danhong injection in patients with septic myocardial injury through a prospective randomized controlled trial.
- Trial name
- NCT07375862
- Testing
- Danhong injection, Saline
- Volunteers
- 140 people
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Infertility, Male
Experimental Round Spermatid Injection (ROSI) to Treat Infertile Couples
The purpose of this research study is to evaluate if special types of cells called round spermatids can be gathered from men with non-obstructive azoospermia and used (in absence of elongated spermatids and spermatozoa) to…
- Trial name
- ROSI (NCT04298255)
- Testing
- Round Spermatid Injection (ROSI), Half ROSI-half Sperm Donor Fertilization
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- Wake Forest University Health Sciences
MECP2 Duplication Syndrome
A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR RNA-editing Therapy in Patients with Mecp2 Duplication Syndrome, a Rare Orphan Disease (HERO)
Methyl-CpG binding protein 2 (MECP2) is a dosage-sensitive, X-linked gene critical for central nervous system development and functional maintenance, which gain-of-function causes MECP2 duplication syndrome (MDS).
- Trial name
- HERO (NCT06615206)
- Testing
- HG204
- Where
- China
- Volunteers
- 6 people
- Sponsor
- HuidaGene Therapeutics Co., Ltd.
CD19-positive Relapsed or Refractory B-cell Malignancies
UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.
This study is designed for exploring the preliminary safety and efficacy of the recombinant allogeneic healthy γδT cells transduced with the anti-CD19 lentiviral vector in patients with CD19-positive B cell hematolymphatic…
- Trial name
- NCT06092047
- Testing
- UTAA09 cells for infusion, Fludarabine, Cyclophosphamide
- Where
- China
- Volunteers
- 10 people
- Sponsor
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Bronchiolitis
Peginterferon α-2b Injection for the Treatment of Pediatric RSV Bronchiolitis
This is a multicenter, randomized, positive-controlled, non-inferiority clinical study, planning to enroll 90 children with bronchiolitis caused by respiratory syncytial virus infection, to evaluate the safety and efficacy of…
- Trial name
- NCT06827249
- Testing
- Peginterferon α-2b injection, Recombinant Human Interferon α2b
- Where
- 3 sites in China
- Volunteers
- 90 people
- Sponsor
- Children's Hospital of Soochow University
Polycythemia Vera
Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)
This is a multicenter, open-label Phase I clinical trial of BEBT-507 in subjects with polycythemia vera(PV). Phase Ia is a single-agent dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK)…
- Trial name
- NCT07012109
- Testing
- BEBT-507 Injection
- Where
- China
- Volunteers
- 90 people
- Sponsor
- BeBetter Med Inc
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.